Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

瑞泰 - NMPA Drug Approval Details

Approvals/NMPA/Ramipril Tablets

Approved

化学药品

Ramipril Tablets

Sanofi-Aventis Deutschland Gmbh🇨🇳 National Medical Products Administration

Approval Date: Dec 31, 2020
Approval ID: 887rFbZL4EV
Company: Sanofi-Aventis Deutschland Gmbh
Type: 化学药品

Approval Details

Approval Id: 887rFbZL4EV
Approval Number: 国药准字HJ20140440
Generic Name: 雷米普利片
Generic Name En: Ramipril Tablets
Trade Name: 瑞泰
Brand Name: 瑞泰
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 5mg
Reg Date: 2020-12-31
Expired Date: 2025-12-30
Company Name: Sanofi-Aventis Deutschland Gmbh
Production Company Name: SANOFI SRL
Company Detail Path: /organization/cd084d0e38f57d36/sanofi-aventis-deutschland-gmbh
Production Company Detail Path: /organization/44298153e3aef302/sanofi-srl

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 31, 2020

Approval ID

887rFbZL4EV

Type

化学药品

Back to NMPA Approvals